^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
GENE:

IGK (Immunoglobulin Kappa Locus)

i
Other names: IGK, Immunoglobulin Kappa Locus, IGK@
Associations
Trials
1d
EXPRESSION OF IMMUNOGLOBULIN LIGHT CHAIN GENES IN STEREOTYPED CASES FROM UKRAINIAN COHORT OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS. (PubMed, Exp Oncol)
The non-stochastic distribution of the IGKV/LV gene expression in the individual stereotyped subsets was confirmed. Taking into account the complementary role of the light chains in antigen recognition by the clonotypic BCRs, it was suggested that the subsets with the heterogeneous IGK/LV expression might be reclassified and divided into separate subgroups based on the IGHV and IGK/LV association.
Journal
|
IGH (Immunoglobulin Heavy Locus) • IGK (Immunoglobulin Kappa Locus)
4ms
Gene expression and alternative splicing analysis in a large-scale Multiple Sclerosis study. (PubMed, medRxiv)
We also identified exon skipping events and spontaneous single nucleotide polymorphisms in membrane associated ring-CH-type finger 1 ( MARCHF1 ), UDP glycosyltransferase 8 ( UGT8 ), and other genes important in autoimmunity and neurodegeneration. Overall, we identified unique genes, pathways, and novel splicing events affecting disease progression that can be further investigated as potential novel drug targets for MS treatment.
Journal
|
IGK (Immunoglobulin Kappa Locus)
5ms
Primary diffuse large B-cell lymphoma of the central nervous system identified with CSF biomarkers. (PubMed, BMC Neurol)
Taken together, 5 CSF biomarkers (IL-10, IL-10/IL-6 ratio, CXCL13, MYD88 mutation and monoclonal IG gene rearrangements) were strongly indicative of a PCNSL. Using innovative CSF biomarkers can be sensitive and complementary to traditional CSF analysis and brain biopsy in the diagnosis of PCNSL, potentially allowing for earlier diagnosis and treatment.
Journal
|
MYD88 (MYD88 Innate Immune Signal Transduction Adaptor) • CXCL13 (Chemokine (C-X-C motif) ligand 13) • IL10 (Interleukin 10) • IL6R (Interleukin 6 receptor) • IGK (Immunoglobulin Kappa Locus)
9ms
Assessment of Bone Marrow Involvement in B-Cell non-Hodgkin Lymphoma Using Immunoglobulin Gene Rearrangement Analysis with Next-Generation Sequencing. (PubMed, J Clin Lab Anal)
NGS-based clonality analysis is an analytic platform with a substantial overall agreement with histopathological analysis. Assessment of both IGH and IGK genes for the clonal rearrangement analysis could be considered for the optimal diagnostic performance of BMI detection in B-cell NHL.
Journal • Next-generation sequencing
|
IGK (Immunoglobulin Kappa Locus)
10ms
A Rare Case of Non-IgM Lymphoplasmacytic Lymphoma with Unusual Lack of Immunoglobulin Light Chain Production. (PubMed, Am J Case Rep)
The patient received 6 cycles of rituximab and bendamustine treatment, and no residual marrow involvement was found on the follow-up bone marrow biopsy. CONCLUSIONS We report a non-IgM LPL case featuring no light chain production and no heavy chain secretion, which we believe is the first reported case of this kind in the literature.
Journal
|
MYD88 (MYD88 Innate Immune Signal Transduction Adaptor) • CXCR4 (Chemokine (C-X-C motif) receptor 4) • IGK (Immunoglobulin Kappa Locus)
|
MYD88 L265P • CXCR4 mutation
|
Rituxan (rituximab) • bendamustine
over1year
IMMUNOGLOBULIN GENE REARRANGEMENT IN KOREAN PATIENTS WITH B-LYMPHOBLASTIC LEUKEMIA – AN IMMUNOPHENOTYPE AND REPERTOIRE ANALYSIS (EHA 2023)
Clonal IGH and/or IGK rearrangements were observed in 95.7% of pediatric patients and 87.0% of adult patients; however, only 82.9% of pediatric patients had clonal rearrangements, which is suitable for MRD monitoring. Absence or low clonal IGH/IGK read was observed in 60% of pro-B-ALL in pediatric patients. TRB and TRG testswere helpful for finding clonal sequences.
Clinical
|
IGH (Immunoglobulin Heavy Locus) • IGK (Immunoglobulin Kappa Locus)
2years
T Cell Epitope Prediction within the Clonotypic Immunoglobulin Heavy and Light Chains in Patients with Multiple Myeloma (ASH 2022)
Many of the identified peptides derive from SHM, implying that the SHM which shapes the MM BcR IG repertoire may produce immunogenic CD4+/CD8+ T cell epitopes. Their actual immunogenicity has to be tested in ex vivo studies, currently underway by our group.
Clinical • IO biomarker
|
CD8 (cluster of differentiation 8) • IGH (Immunoglobulin Heavy Locus) • HLA-DRB1 (Major Histocompatibility Complex, Class II, DR Beta 1) • CD4 (CD4 Molecule) • SDC1 (Syndecan 1) • HLA-B (Major Histocompatibility Complex, Class I, B) • IGKC (Immunoglobulin Kappa Constant) • HLA-C (Major Histocompatibility Complex, Class I, C) • IGK (Immunoglobulin Kappa Locus)